SIMPLEX TRADING, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$25
-44.4%
703
-60.6%
0.00%
Q1 2023$45
-100.0%
1,786
-44.6%
0.00%
Q3 2022$106,000
-7.8%
3,222
-1.5%
0.00%
Q2 2022$115,000
-1.7%
3,270
+28.3%
0.00%
Q1 2022$117,000
-92.3%
2,548
-88.9%
0.00%
-100.0%
Q4 2021$1,518,000
-44.7%
22,902
-29.1%
0.00%
-33.3%
Q3 2021$2,745,000
+18.8%
32,311
+15.8%
0.00%
+50.0%
Q2 2021$2,310,00027,896
-9.6%
0.00%
Q1 2021$0
-100.0%
30,850
+17.2%
0.00%
-100.0%
Q4 2020$2,018,000
+8.0%
26,313
-39.4%
0.00%0.0%
Q3 2020$1,869,000
-0.8%
43,414
-0.5%
0.00%0.0%
Q2 2020$1,885,000
+42.6%
43,654
-5.1%
0.00%
+50.0%
Q1 2020$1,322,000
-17.7%
45,984
+81.5%
0.00%
-50.0%
Q4 2019$1,607,000
+78.0%
25,339
-21.0%
0.00%
+33.3%
Q3 2019$903,000
-27.4%
32,069
-31.7%
0.00%0.0%
Q2 2019$1,244,000
+667.9%
46,978
+429.3%
0.00%
Q1 2019$162,000
+16.5%
8,876
-21.0%
0.00%
Q4 2018$139,000
+4.5%
11,231
+61.0%
0.00%
Q3 2018$133,000
-83.7%
6,974
-88.4%
0.00%
-100.0%
Q2 2018$818,000
+976.3%
60,189
+467.1%
0.00%0.0%
Q1 2018$76,000
-30.9%
10,613
-29.3%
0.00%
-57.1%
Q3 2016$110,000
+266.7%
15,003
+161.3%
0.01%
+250.0%
Q2 2016$30,0005,7420.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders